Zacks' 7 Best Stocks for May, 2013
FREE Report for Zacks.com
Visitors Only

They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.

Today, you can see them free.

Close This Panel X

Are you a new Zacks Member or a visitor to Zacks.com?

Recent Quotes

No Recent Quote currently available

My Portfolio

My Portfolio Tracker

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Stocks on the Move 05/17/2013

Company Name Symbol %Change
VIASAT INC VSAT
19.35%
OLD SECOND B OSBC
5.76%
GAMCO INVEST GBL
4.61%
CORNING INC GLW
4.47%
SYNCHRONOSS SNCR
4.23%

Praxair Retains Neutral Rating

by Zacks Equity Research

November 13, 2012 | Comments : 0 Recommended this article: (0)

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.

We currently maintained a Neutral recommendation on industrial gas producer and supplier, Praxair Inc. ( PX - Analyst Report ) based on insignificant share driving catalysts in the near term.

A downward revision in management’s outlook due to a weak operating environment for the fourth quarter has dampened our view on the stock. Earnings per share guidance for 2012 has been lowered from $5.60-$5.70 to the $5.54-$5.59 range while revenue is now projected to be roughly $11.2 billion as against the $11.2-$11.5 billion expected earlier.

Even the third quarter 2012 results were not impressive as earnings per share in the quarter fell 1% year over year to $1.39; however, the results matched the Zacks Consensus Estimate. Revenue was down 4% to $2.8 billion due largely to a negative currency translation impact. Geographically, all markets were soft, except for Asia where the company’s revenue grew by 3%.

These near-term concerns have forced us to remain on the sidelines for Praxair currently. Despite these concerns, the long-term growth prospects remain an attractive feature of the stock. The company’s policy of returning values to shareholders through dividends and share buybacks as well as strategic acquisitions and joint ventures, the one with nexAir, for instance, bode well for Praxair and will also help in achieving its long-term target of annual organic sales growth of 8%-12% by 2015.

Moreover, growing popularity of Praxair’s technologically advanced work has led to around $2.6 billion in backlogs for the company. The current Zacks Consensus Estimate for the fourth quarter 2012 is $1.39, representing a year-over-year decrease of 1.9%. Estimates for the fiscal years 2012 and 2013 are $5.58 and $6.24, reflecting annual growth of 2.9% and 11.8%, respectively.

The stock also carries a Zacks #3 Rank, implying a short-term (1-3 months) Hold rating. Its prime competitor Air Products & Chemicals Inc. ( APD - Analyst Report ) has a Zacks #4 (Sell) rating. The company in its September ending quarter reported earnings per share of $1.42, missing the Zacks Consensus Estimate by 2 cents. Estimate for the December ending quarter currently stands at $1.29 per share.

Email Print Share Rate Pos Rate Neg

Read/Post Comments (0) | Recommended this article (0)

Please login to Zacks.com or register to post a comment.

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.